DV Biomed Co., Ltd. (TPEX:6539)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.00
+0.05 (0.12%)
Jun 18, 2026, 2:49 PM CST
Market Cap998.32M -41.7%
Revenue (ttm)794.18M +38.5%
Net Income7.74M -91.3%
EPS0.32 -91.4%
Shares Out 24.35M
PE Ratio124.24
Forward PEn/a
Dividend0.60 (1.46%)
Ex-Dividend DateJun 17, 2026
Volume4,006
Open40.95
Previous Close40.95
Day's Range40.95 - 41.00
52-Week Range39.90 - 61.95
Beta0.12
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About DV Biomed

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skincare; and beauty products and services, as well as operates beauty therapy centers. The company was founded in 2011 and is based in Taipei, Taiwan. [Read more]

Sector Healthcare
Founded 2011
Employees 326
Stock Exchange Taipei Exchange
Ticker Symbol 6539
Full Company Profile

Financial Performance

In 2025, DV Biomed's revenue was 794.18 million, an increase of 38.46% compared to the previous year's 573.57 million. Earnings were 7.74 million, a decrease of -91.31%.

Financial Statements